News

Financial Buzz11h

Recursion Pharmaceuticals (RXRX) Stock Jumps After Acquiring Full Rights to REV102 for Rare Bone Disorder

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) saw its stock surge 19% Monday morning following the announcement of its ...

Recursion Pharmaceuticals Acquires Full Rights to REV102, Potential Oral Therapy for Rare Bone Disorder Hypophosphatasia

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the best small cap AI stocks to buy according to analysts. On July 8, ...